ES2091940T3 - Composicion basada en oligomero de hemoglobina y procedimiento para elaborar la misma. - Google Patents

Composicion basada en oligomero de hemoglobina y procedimiento para elaborar la misma.

Info

Publication number
ES2091940T3
ES2091940T3 ES91914918T ES91914918T ES2091940T3 ES 2091940 T3 ES2091940 T3 ES 2091940T3 ES 91914918 T ES91914918 T ES 91914918T ES 91914918 T ES91914918 T ES 91914918T ES 2091940 T3 ES2091940 T3 ES 2091940T3
Authority
ES
Spain
Prior art keywords
hemoglobin
preparing
procedure
same
based composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91914918T
Other languages
English (en)
Inventor
Deanna J Nelson
Ton That Hai
Ana Srnak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24274925&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2091940(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2091940T3 publication Critical patent/ES2091940T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Polyethers (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA MEZCLA NO INMUNOGENICA DE MONOMEROS MODIFICADOS CON BASE DE HEMOGLOBINA Y OLIGOMEROS PRODUCIDOS POR LA POLIMERIZACION DE UNA SOLUCION CON BASE DE HEMOGLOBINA EN LA PRESENCIA DE UN ANILLO HETEROCICLICO DE TRES MIEMBROS, POR EJ, OXIRANO DE POLIETER. LA COMPOSICION DE HEMOGLOBINA MODIFICADA TIENE UN P SUB 50 AL MENOS EQUIVALENTE AL P SUB 50 DE LA HEMOGLOBINA DE CELULA SANGUINEA HUMANA.
ES91914918T 1990-08-17 1991-08-15 Composicion basada en oligomero de hemoglobina y procedimiento para elaborar la misma. Expired - Lifetime ES2091940T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56931690A 1990-08-17 1990-08-17

Publications (1)

Publication Number Publication Date
ES2091940T3 true ES2091940T3 (es) 1996-11-16

Family

ID=24274925

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91914918T Expired - Lifetime ES2091940T3 (es) 1990-08-17 1991-08-15 Composicion basada en oligomero de hemoglobina y procedimiento para elaborar la misma.

Country Status (8)

Country Link
EP (1) EP0496866B1 (es)
JP (1) JP2689023B2 (es)
AT (1) ATE140389T1 (es)
CA (1) CA2067241A1 (es)
DE (1) DE69120925T2 (es)
DK (1) DK0496866T3 (es)
ES (1) ES2091940T3 (es)
WO (1) WO1992003153A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312808A (en) * 1989-11-22 1994-05-17 Enzon, Inc. Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
US5650388A (en) * 1989-11-22 1997-07-22 Enzon, Inc. Fractionated polyalkylene oxide-conjugated hemoglobin solutions
DK145092D0 (es) * 1992-12-03 1992-12-03 Novo Nordisk As
US6242417B1 (en) * 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
JP2002506463A (ja) * 1998-04-24 2002-02-26 バイオジェン，インコーポレイテッド 利尿機能および腎機能を回復するためのアデノシンａ１レセプターアンタゴニスト含有組成物および方法
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
US20210352887A1 (en) * 2018-10-12 2021-11-18 VirTech Bio, Inc. Oxygenation media for ex-vivo preservation of organs and tissues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
JPS60258126A (ja) * 1984-06-02 1985-12-20 Teruo Tomota 重合化ヘモグロビンの製造方法
US4598064A (en) 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
IL87708A (en) * 1988-09-08 1994-04-12 Technion Inst For Research And Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
IL87707A (en) * 1988-09-08 1994-06-24 Technion Inst For Research And Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof

Also Published As

Publication number Publication date
DK0496866T3 (da) 1996-08-12
EP0496866A1 (en) 1992-08-05
DE69120925D1 (de) 1996-08-22
DE69120925T2 (de) 1997-02-13
WO1992003153A1 (en) 1992-03-05
JP2689023B2 (ja) 1997-12-10
CA2067241A1 (en) 1992-02-18
ATE140389T1 (de) 1996-08-15
JPH05502240A (ja) 1993-04-22
EP0496866B1 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
ES2147720T3 (es) Factor de celulas madre.
EP0502113A4 (en) Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
FI871983A7 (fi) Perfluoripolyeettereitä, jotka eivät sisällä peroksidihappea ja joiden perfluoripolyeetteriketjussa on perfluoriepoksiryhmiä, sekä niiden johdannaisia.
DK0633721T3 (da) Rensning af blodplader med 8-metoxypsoralen
ES2092183T3 (es) Procedimiento para la preparacion de poli(tereftalato de butileno) a partir de residuos de poli(tereftalato de etileno).
AR008680A1 (es) Substitutos de plaquetas y metodos de conjugacion apropiados para su preparacion
BR9910251A (pt) Estimulação hematopoiética
IL93098A0 (en) Alkylated polyethylenimine derivatives,process for their preparation and pharmaceutical preparations containing them
ATE92930T1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
MX9201298A (es) Nuevos conjugados de proteinas con poli etilen glicol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ATE358176T1 (de) Menschliche dnase
IT1205978B (it) Derivati di dicloroanilina,composizioni farmaceutiche che li contengono e procedimento per produrli
ES2055048T3 (es) Liofilizacion de eritrocitos y medios para usarse en ella.
HUT63459A (en) Blood factors produced by recommbinant process, process for expressing them, as well as recombinant vaccine viruses used in the process
ES2091940T3 (es) Composicion basada en oligomero de hemoglobina y procedimiento para elaborar la misma.
DE69028144D1 (de) Verfahren zum Lagern von Erythrozyten
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
SE470311B (sv) Aromatiska föreningar, förfarande för framställning därav och deras användning inom human- veterinärmedicinen och i kosmetika
DK124787D0 (da) Peptider indeholdende op til 8-aminosyregrupperinger og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
HUP9901161A2 (hu) Módosított aktivitású hibrid VIII. faktor
IT8920186A0 (it) Catalizzatore di polimerizzazione, procedimento per la sua preparazione e suo impiego nella omo e copolimerizzazione di etilene.
ES8206545A1 (es) Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin
ES2022501B3 (es) Procedimiento para preparar un aducto de lactato calcico y glicerol, y su empleo.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 496866

Country of ref document: ES